Guest Contributor

ATI announces first company spin-off

Guest Contributor
April 24, 2007

Aggregate Therapeutics Inc's (ATI) novel approach to intellectual property management of stem cell technologies has produced its first company spin-off. Regium is composed of several licensed and optioned technologies from Canadian institutions represented by ATI, which will benefit from the recently concluded partnership with MaRS Discovery District.

... Please become a Member or login to read the rest of this article ...


Other stories mentioning these organizations, people and topics

Other News

Stem Cell Network teaming with MaRs to accelerate commercialization efforts

Modelled on Israeli partnership Canada launches first program devoted to bi-national collaborative R&D projects

Health research increases share of Canadian R&D expenditures — StatsCan

Ontario government announces $15 million for Structural Genomics Consortium






Events For Leaders in
Science, Tech, Innovation, and Policy


Discuss and learn from those in the know at our virtual and in-person events.



See Upcoming Events










You have 0 free articles remaining.
Don't miss out - start your free trial today.

Start your FREE trial    Already a member? Log in






Top

By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively in accordance with our Privacy Policy and Terms of Service.